All In MedTech

FDA Clearance Tracker · P790017

USCI DILATATION CATHETER

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Mar 24, 1980 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Mar 24, 1980

Approved (reclassified)

Time to decision

283 days

Received Jun 15, 1979. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class II

The decision

FDA number
P790017
Device name
USCI DILATATION CATHETER
Applicant location
Galway
Received
Jun 15, 1979
Decided
Mar 24, 1980
Decision
Approved (reclassified)
Supplements
86 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class II
Regulation
21 CFR 870.5100

Every decision under product code LOX

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code LOX (Catheters, transluminal coronary angioplasty, percutaneous).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Medtronic, Ireland

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.